References
- RabeKFHurdSAnzuetoAGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med200717653255517507545
- ChungKFAdcockIMMultifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destructionEur Respir J2008311334135618515558
- CaramoriGRomagnoliMCasolariPNuclear localisation of p65 in sputum macrophages but not in sputum neutrophils during COPD exacerbationsThorax20035834835112668802
- HanselTTBarnesPJNew drugs for exacerbations of chronic obstructive pulmonary diseaseLancet200937474475519716967
- WeigelNLMooreNLSteroid receptor phosphorylation: a key modulator of multiple receptor functionsMol Endocrinol2007212311231917536004
- IrusenEMatthewsJGTakahashiABarnesPJChungKFAdcockIMp38 Mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthmaJ Allergy Clin Immunol200210964965711941315
- Galliher-BeckleyAJCidlowskiJAEmerging roles of glucocorticoid receptor phosphorylation in modulating glucocorticoid hormone action in health and diseaseIUBMB Life20096197998619787703
- GuhaMMackmanNLPS induction of gene expression in human monocytesCell Signal200113859411257452
- SaccaniSPantanoSNatoliGp38-Dependent marking of inflammatory genes for increased NF-kappa B recruitmentNat Immunol20023697511743587
- DeanJLSullyGClarkARSaklatvalaJThe involvement of AU-rich element-binding proteins in p38 mitogen-activated protein kinase pathway-mediated mRNA stabilisationCell Signal2004161113112115240006
- SchettGZwerinaJFiresteinGThe p38 mitogen-activated protein kinase (MAPK) pathway in rheumatoid arthritisAnn Rheum Dis20086790991617827184
- RendaTBaraldoSPelaiaGIncreased activation of p38 MAPK in COPDEur Respir J200831626917959643
- CulpittSVRogersDFShahPImpaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2003167243112406856
- MillerALWebbMSCopikAJp38 Mitogen-activated protein kinase (MAPK) is a key mediator in glucocorticoid-induced apoptosis of lymphoid cells: correlation between p38 MAPK activation and site-specific phosphorylation of the human glucocorticoid receptor at serine 211Mol Endocrinol2005191569158315817653
- ArmstrongJHarbronCLeaSSynergistic Effects of p38 mitogen-activated protein kinase inhibition with a corticosteroid in alveolar macrophages from patients with chronic obstructive pulmonary diseaseJ Pharmacol Exp Ther201133873274021610141
- MackayAJHurstJRCOPD exacerbations: causes, prevention, and treatmentImmunol Allergy Clin North Am2013339511523337067
- BarnesPJCorticosteroid resistance in patients with asthma and chronic obstructive pulmonary diseaseJ Allergy Clin Immunol201313163664523360759
- BhavsarPKhorasaniNHewMJohnsonMChungKFEffect of p38 MAPK inhibition on corticosteroid suppression of cytokine release in severe asthmaEur Respir J20103575075619840967
- GoldsteinDMKuglstatterALouYSothMJSelective p38alpha inhibitors clinically evaluated for the treatment of chronic inflammatory disordersJ Med Chem2010532345235319950901
- TeboJDerSFrevelMKhabarKSWilliamsBRHamiltonTAHeterogeneity in control of mRNA stability by AU-rich elementsJ Biol Chem2003278120851209312556523
- BhattacharyyaSGuttiUMercadoJMooreCPollardHBBiswasRMAPK signaling pathways regulate IL-8 mRNA stability and IL-8 protein expression in cystic fibrosis lung epithelial cell linesAm J Physiol Lung Cell Mol Physiol2011300L81L8720952496
- LauWKChanSCLawACIpMSMakJCThe role of MAPK and Nrf2 pathways in ketanserin-elicited attenuation of cigarette smoke-induced IL-8 production in human bronchial epithelial cellsToxicol Sci201212556957722048642
- FogelRShieldsKChristensenJA phase II, randomised, placebo controlled trial of 12 weeks treatment with an oral p38 inhibitor in patients with COPD on a background of ICS/LABAEur Respir J201342Suppl 57186
- BirrellMAWongSCatleyMCBelvisiMGImpact of tobacco-smoke on key signaling pathways in the innate immune response in lung macrophagesJ Cell Physiol2008214273717541958
- MedicherlaSFitzgeraldMFSpicerDp38alpha-selective mitogen-activated protein kinase inhibitor SD-282 reduces inflammation in a subchronic model of tobacco smoke-induced airway inflammationJ Pharmacol Exp Ther200832492192918056868
- BouazzaBDebba-PavardMAmraniYBasal p38 mitogen-activated protein kinase regulates unliganded glucocorticoid receptor function in airway smooth muscle cellsAm J Respir Cell Mol Biol201450230131524024586
- ChenWDangTBlindRDGlucocorticoid receptor phosphorylation differentially affects target gene expressionMol Endocrinol2008221754176618483179
- Galliher-BeckleyAJWilliamsJGCidlowskiJALigand-independent phosphorylation of the glucocorticoid receptor integrates cellular stress pathways with nuclear receptor signalingMol Cell Biol2011314663467521930780
- BouazzaBKrytskaKDebba-PavardMCytokines alter glucocorticoid receptor phosphorylation in airway cells: role of phosphatasesAm J Respir Cell Mol Biol20124746447322592921
- WangBPalomaresKParobchakNGlucocorticoid receptor signaling contributes to constitutive activation of the noncanonical NF-κB pathway in term human placentaMol Endocrinol20132720321123239753
- AvenantCKotitschkeAHapgoodJPGlucocorticoid receptor phosphorylation modulates transcription efficacy through GRIP-1 recruitmentBiochemistry20104997298520047289
- Galliher-BeckleyAJWilliamsJGCollinsJBCidlowskiJAGlycogen synthase kinase 3beta-mediated serine phosphorylation of the human glucocorticoid receptor redirects gene expression profilesMol Cell Biol2008287309732218838540
- ItohMAdachiMYasuiHTakekawaMTanakaHImaiKNuclear export of glucocorticoid receptor is enhanced by c-Jun N-terminal kinase-mediated phosphorylationMol Endocrinol2002162382239212351702